Q
QuantAbundance

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,857 signal articles · 175 in last 24h · 157,324 total before filter · latest 1h ago
175last 24h
859last 7d
139● bullish (7d)
79● bearish (7d)
214publishers
AllMacro197Earnings136M&A100Regulatory18Product20Analyst23
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Delivery Outlook Shows Tesla (TSLA)’s Core Business Under Pressure. Its Next Growth Engine Must Deliver
Insider Monkey9d agoneutral
Delivery Outlook Shows Tesla (TSLA)’s Core Business Under Pressure. Its Next Growth Engine Must Deliver

Goldman Sachs has cut its delivery forecast for Tesla, Inc. (NASDAQ:TSLA) while citing weaker sales trends across the company’s most important markets. The investment bank slashed its Q3 delivery forecast to 435,000 vehicles from 490,000. It also lowered its Q4 delivery forecast to 475,000 vehicles from 515,000. The question now is whether Tesla’s demand weakness […]

3 US Stocks That Could Gain If Buyers Shift Away From India
Simply Wall St.9d agobullish
3 US Stocks That Could Gain If Buyers Shift Away From India

A new US law that could slap tariffs of up to 100% on imports from big buyers of Russian energy, including India, suddenly puts long trusted trade routes in question and opens the door for alternative suppliers. That shift creates a potential opening for US-focused stocks exposed to this news, and investors who ignore it risk missing a meaningful realignment in global sourcing. This article examines the law’s potential ripple effects and highlights 3 stocks from the screener that could be...

Is Regal Rexnord (RRX) Trading At A Discount To Cash Flow?
Simply Wall St.9d agoneutral
Is Regal Rexnord (RRX) Trading At A Discount To Cash Flow?

Regal Rexnord has delivered a 13.7% gain over the past 5 years, yet its recent pullback raises a simple question for you as an investor. Is the current share price of US$148.05 adequately explained by the cash flows the business is expected to generate? A 13.7% return over 5 years puts real money on the line for holders, so the crucial issue is whether those cash flows still justify staying invested at today's level. Regal Rexnord's ability to turn earnings into cash, and decide how much of...

Lucid (LCID) Rises After Bolt Partnership, But Cash Burn Remains a Concern
Insider Monkey9d agobullish
Lucid (LCID) Rises After Bolt Partnership, But Cash Burn Remains a Concern

On September 17, Lucid Group, Inc. (NASDAQ:LCID) and Bolt, a leading European shared mobility platform, announced a strategic partnership to develop and deploy autonomous mobility services across Europe. This sent shares of Lucid Group, Inc. (NASDAQ:LCID) higher, and the stock ended the trading session with gains of nearly 6%. The partnership will combine Lucid Group, […]

Roblox (RBLX) Is Up 5.1% After Launching “Roblox Everywhere” Standalone Apps Initiative Has The Bull Case Changed?
Simply Wall St.9d agoneutral
Roblox (RBLX) Is Up 5.1% After Launching “Roblox Everywhere” Standalone Apps Initiative Has The Bull Case Changed?

Earlier in September 2026, Roblox Corporation announced “Roblox Everywhere,” a program that will let creators publish their experiences as standalone applications across multiple platforms, expanding distribution beyond the core Roblox app. This shift could reshape how value is shared on the platform by turning individual Roblox experiences into app-like products that reach users who may never open the main Roblox client. We’ll now explore how opening Roblox experiences as standalone apps...

Hewlett Packard Enterprise (HPE) Wins Top Zacks Rank, Is It Still Undervalued?
Simply Wall St.9d agobullish
Hewlett Packard Enterprise (HPE) Wins Top Zacks Rank, Is It Still Undervalued?

Hewlett Packard Enterprise (HPE) has drawn fresh attention after outperforming its Computer and Technology sector peers this year, as analysts raised earnings estimates and assigned the stock a top Zacks Rank rating. Recent trading has cooled slightly, with the share price down over the past week, although Hewlett Packard Enterprise still carries a 30-day share price return of 14.36% and a 90-day gain of 28.16% at a latest share price of $60.76. That short term momentum sits on top of a...

Centrus Energy (LEU) Signs Two HALEU Supply Agreements Backing Reactor And Security Demand
Simply Wall St.9d agoneutral
Centrus Energy (LEU) Signs Two HALEU Supply Agreements Backing Reactor And Security Demand

Centrus Energy (NYSE:LEU) agreed to a multi year HALEU supply contract with Antares Nuclear to fuel advanced reactor projects. The company also signed an agreement with Radiant that links its HALEU output to advanced reactors and national security uses. Both arrangements include prepayments intended to expand Centrus Energy's domestic high assay low enriched uranium production capacity. The new Antares and Radiant HALEU deals change the story, but they should not be your only focus. Check...

3 US Stocks Tied To Onshoring That Investors May Want To Watch
Simply Wall St.9d agoneutral
3 US Stocks Tied To Onshoring That Investors May Want To Watch

Trade disputes, tech regulations and shifting rules on critical exports are pulling global supply chains in new directions, turning onshoring from a buzzword into a real capital spending theme. That creates a window for investors who want exposure to solid manufacturers linked to domestic production rather than far flung networks. This article examines three large cap stocks connected to these developments and outlines key reasons each one may warrant closer review at this time. The three...

Tempus AI (TEM) Is Up 31.9% After Launching 100,000‑Genome AI Research Platform Initiative
Simply Wall St.9d agoneutral
Tempus AI (TEM) Is Up 31.9% After Launching 100,000‑Genome AI Research Platform Initiative

Earlier this month, Tempus AI announced a multi‑year initiative to build a research platform of 100,000 whole genomes linked to longitudinal clinical, imaging, pathology and outcome data, with plans to eventually scale toward one million genomes and offer broad access via its Tempus Lens environment by mid‑2027. This move extends Tempus AI beyond targeted panels into whole‑genome sequencing, creating a model‑ready, multimodal dataset specifically tailored for AI‑driven disease and drug...

Is Novanta’s (NOVT) High-Margin Revenue Momentum Redefining Its Competitive Moat?
Simply Wall St.9d agoneutral
Is Novanta’s (NOVT) High-Margin Revenue Momentum Redefining Its Competitive Moat?

In recent commentary, Novanta (NASDAQ:NOVT) has been highlighted for its multi-year annual revenue growth of 10.7% and a gross margin of 44.4%, reflecting perceived market share gains and strong product positioning. This attention centers on Novanta’s combination of demand acceleration expectations and high-margin products, which analysts view as evidence of superior competitive capabilities. Next, we will examine how this focus on Novanta’s revenue momentum and margins may influence the...

Iovance Biotherapeutics (IOVA) Stock Fair Value Edges Higher On Amtagvi Margin Progress
Simply Wall St.9d agoneutral
Iovance Biotherapeutics (IOVA) Stock Fair Value Edges Higher On Amtagvi Margin Progress

The analyst fair value estimate for Iovance Biotherapeutics has shifted from US$9.33 to US$10.00 per share, reflecting a fresh round of updated models. Recent research points to Amtagvi revenue trends, margin progression, and the potential impact of upcoming data such as IOV-LUN-202 as key reasons behind the new cluster of price targets in the US$10 to US$15 range. Read on to see how these moves fit into the broader analyst narrative and how to track the next set of updates. Analyst Price...